Live Breaking News & Updates on Pertuzumab

Stay updated with breaking news from Pertuzumab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Trastuzumab Plus Pertuzumab Provides Sustained iDFS Benefit in HER2+ Breast Cancer

A chemotherapy-free regimen of trastuzumab plus pertuzumab generated a strong 3-year iDFS rate in patients with HER2-positive early breast cancer. ....

Antonio Llombart Cussac , University Hospital Arnau De Vilanova , Oncology Service , Medical Oncology Service , Her2 Positive Early Breast Cancer , Chemotherapy Free Regimen ,

NRG-GY018 and RUBY Trials in Endometrial Cancer

Experts on endometrial cancer review the NRG-GY018 and RUBY clinical trials. ....

Ramez Eskander , Matthewa Powell , Ursulaa Matulonis , Bhavana Pothuri , Shannonn Westin , Endometrial Cancer , Ruby Trial , Asco 2023 , Nrg Gy018 , Sgo 2023 , Mismatch Repair ,

Ongoing Research in HER2+ Metastatic Breast Cancer

An overview of agents and treatment strategies currently being investigated in HER2+ metastatic breast cancer. ....

Megan Kruse , Her2 Metastatic Breast Cancer , Precious Trial , T Dm1 , Overall Survival , Asco 2023 , Her2 Targeted Therapy , Leptomeningeal Disease ,

Patient Profile: A 68-Year-Old Woman With HER2+ Metastatic Breast Cancer

Expert oncologist Virginia Kaklamani, MD, DSc, shares her perspectives on a patient case of HER2+ metastatic breast cancer (mBC) treated with multiple lines of therapy. ....

Improving Outcomes , Breast Cancer , Translating Evidence , Clinical Practice , Year Old Woman With , Metastatic Breast Cancer , Virginia Kaklamani , Her2 Positive , Her2 Breast Cancer , Interstitial Lung Disease , Thp Therapy , Cleopatra Trial , Cleopatra Regimen , Cleopatra Study , Trastuzumab Deruxtecan , T Dxd , Destiny Breast03 , Trastuzumab Emtansine , Third Line Therapy , Third Line Treatment , Later Line Therapy , Her2climb Trial , Brain Mets , Brain Metastases ,

Overview of the HER2+ Metastatic Breast Cancer Treatment Armamentarium

A key opinion leader in breast cancer management shares insight on the treatment armamentarium for patients with HER2+ disease. ....

Improving Outcomes , Breast Cancer , Translating Evidence , Clinical Practice , Metastatic Breast Cancer Treatment , Metastatic Breast Cancer , Her2 Positive , Her2 Breast Cancer , Thp Therapy , Cleopatra Regimen , Trastuzumab Emtansine , Destiny Breast03 , Trastuzumab Deruxtecan , T Dxd , Destiny Breast02 , Her2climb Trial , Brain Mets , Brain Metastases , Nala Trial , Nala Study , Novel Therapy , Combination Therapy ,